可孚医疗
(301087)
| 流通市值：34.24亿 | | | 总市值：79.09亿 |
| 流通股本：9057.43万 | | | 总股本：2.09亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 807,154,893.3 | 2,853,694,939.62 | 2,123,962,814.37 | 1,519,115,209.72 |
| 营业收入 | 807,154,893.3 | 2,853,694,939.62 | 2,123,962,814.37 | 1,519,115,209.72 |
| 二、营业总成本 | 676,812,278.56 | 2,594,385,730.52 | 1,866,775,975.51 | 1,294,121,165.18 |
| 营业成本 | 404,949,938.3 | 1,618,660,760.96 | 1,160,503,818.1 | 819,475,746.23 |
| 税金及附加 | 6,904,197.11 | 28,831,185.92 | 21,865,708.37 | 10,885,845.6 |
| 销售费用 | 218,526,875.35 | 740,704,222.71 | 525,231,626.62 | 353,587,339.01 |
| 管理费用 | 29,520,343.97 | 110,921,003.97 | 91,870,067.22 | 62,178,138.84 |
| 研发费用 | 22,369,153.88 | 114,330,448.64 | 79,244,096.66 | 55,428,186.37 |
| 财务费用 | -5,458,230.05 | -19,061,891.68 | -11,939,341.46 | -7,434,090.87 |
| 其中:利息费用 | 2,722,588.16 | 13,502,605.05 | 6,881,627.06 | 8,638,715.46 |
| 其中:利息收入 | 9,533,132.21 | 34,305,257.97 | 23,683,270.61 | 16,937,668.56 |
| 加:公允价值变动收益 | 7,537,888.73 | -1,562,660.43 | 33,363,522.57 | 21,981,035.4 |
| 加:投资收益 | -431,699.64 | 47,715,063.36 | 948,546.64 | -21,199.26 |
| 资产处置收益 | 63,210.33 | 4,591,942.72 | 4,884,517.22 | 2,412,582.03 |
| 资产减值损失(新) | -21,442,996.61 | -52,179,582.1 | -50,683,392.16 | -40,108,496.52 |
| 信用减值损失(新) | -3,096,168.21 | -821,151.75 | 4,768,073.13 | 4,510,589.25 |
| 其他收益 | 6,305,399.39 | 37,675,469.03 | 30,470,381.47 | 21,132,866.92 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 119,278,248.73 | 294,728,289.93 | 280,938,487.73 | 234,901,422.36 |
| 加:营业外收入 | 488,901.59 | 381,604.87 | 196,908.7 | 141,039.08 |
| 减:营业外支出 | 1,024,927.03 | 9,402,077.37 | 4,834,099.16 | 3,791,255.6 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 118,742,223.29 | 285,707,817.43 | 276,301,297.27 | 231,251,205.84 |
| 减:所得税费用 | 17,703,210.12 | 32,837,212.62 | 33,924,360.25 | 31,518,916.19 |
| 六、净利润 | 101,039,013.17 | 252,870,604.81 | 242,376,937.02 | 199,732,289.65 |
| 持续经营净利润 | 101,039,013.17 | 252,870,604.81 | 242,376,937.02 | 199,732,289.65 |
| 归属于母公司股东的净利润 | 101,221,564.63 | 254,279,785.84 | 241,956,330.46 | 198,910,330.69 |
| 少数股东损益 | -182,551.46 | -1,409,181.03 | 420,606.56 | 821,958.96 |
| (一)基本每股收益 | 0.5 | 1.24 | 1.16 | 0.95 |
| (二)稀释每股收益 | 0.49 | 1.24 | 1.16 | 0.95 |
| 九、综合收益总额 | 101,039,013.17 | 252,870,604.81 | 242,376,937.02 | 199,732,289.65 |
| 归属于母公司股东的综合收益总额 | 101,221,564.63 | 254,279,785.84 | 241,956,330.46 | 198,910,330.69 |
| 归属于少数股东的综合收益总额 | -182,551.46 | -1,409,181.03 | 420,606.56 | 821,958.96 |
| 公告日期 | 2024-04-29 | 2024-04-29 | 2023-10-30 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |